drug development strategy
PET center
drug treatment
landscape of drug design
future of drug design
development terminus
PET-radiochemistry
generation of translational PET imaging scientists
Molecular imaging
development of better drugs
health care system
translational scientists
key questions
key role
site
care cycle
disease
central nervous system
high-profile training
pharmaceutical industry
earlier stage reliable answers
top-quality training
main obstacle
pivotal role
clinical phase
treatment effective
main therapeutic areas
big pharmaceutical company
oncology
change of paradigm
cutting-edge research projects
lack
European beneficiary Institutions
transition
Positron Emission Tomography
potential
ESRs
PET3D ETN
fundamental innovation
technology
gap
capacity
sustainable manner
therapy
consortium